Lyfur-CV 625 Tablet
Lyfur-CV 625 Tablet
Cefuroxime (500mg) + Clavulanic Acid (125mg)
Gefrin CV Tablet
Goodman Gilman's Life Sciences Private Limited
Clavulanic Acid 125mg
Pack Size
strip of 6 tablets
Price
Save ₹136
that's 34% off!
About This Medicine
Product description & overview
Lyfur-CV 625 Tablet: Combating Bacterial Infections
Lyfur-CV 625 Tablets are a combination medication containing Cefuroxime (500 mg) plus Clavulanic Acid (125 mg). This potent combination tackles a wide range of bacterial infections, effectively targeting both gram-positive and some gram-negative bacteria.
Cefuroxime is a second-generation cephalosporin known for its broad spectrum activity against various pathogens. Clavulanic acid acts as a beta-lactamase inhibitor, preventing the breakdown of Cefuroxime by certain bacterial enzymes, enhancing its effectiveness in fighting infections.
Lyfur-CV 625 Tablets are specifically designed for patients with various bacterial infections including:
* Ear infections
* Urinary tract infections (UTIs)
* Sinus and throat infections
* Skin and soft tissue infections
Always consult your healthcare professional for diagnosis and prescription before taking any medication.
Active composition
Cefuroxime 500 mg
+1 more active ingredient
About Cefuroxime
Cefuroxime is a cephalosporin antibiotic used to treat various bacterial infections. It works by inhibiting bacterial cell wall synthesis, effectively managing infections. Cefuroxime is crucial for antibacterial therapy. In summary, it plays a vital role in treating bacterial infections.
How It Works
Cefuroxime binds to penicillin-binding proteins, inhibiting peptidoglycan synthesis and compromising bacterial cell wall integrity.
All Active Ingredients
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Consuming alcohol with Lyfur-CV 625 Tablet does not cause any harmful side effects.
High Risk
Pregnancy
Lyfur-CV 625 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Not relevant, as Lyfur-CV 625 Tablet is intended for use in hospitalised patients.
Exercise Caution
Liver
There is limited information available on the use of Lyfur-CV 625 Tablet in patients with liver disease. Please consult your doctor.
Regular Checkup
Breastfeeding
Lyfur-CV 625 Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Consult Doctor
Kidney
There is limited information available on the use of Lyfur-CV 625 Tablet in patients with kidney disease. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Lyfur-CV 625 Tablet